The Glu-urea-Lys (Ahx)-[(HBED-CC)] (PSMA-11) labelled with gallium-68, [68Ga]Ga-PSMA-11, is the radiopharmaceutical of choice for imaging of Prostate Cancer (PCa) (Fendler et al. 2017). This evidence concerns the gene FOLH1 and prostate carcinoma.